Inclusion Criteria: -Japanese male or female ≥ 20 years and ≤ 85 years of age -History of chronic stable HF with reduced ejection fraction, defined as requiring treatment for HF for a minimum of 4 weeks prior to screening -Reated for HF with optimal pharmacological therapy -Left ventricular ejection fraction ≤ 40% at screening.